Literature DB >> 3153321

Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.

W Rascher1, W Rosendahl, I A Henrichs, R Maier, H W Seyberth.   

Abstract

In four boys with congenital nephrogenic diabetes insipidus, plasma arginine-vasopressin (AVP) and urinary excretion of prostaglandins were studied in response to treatment with hydrochlorothiazide and indomethacin. An abnormal relationship between AVP and urine osmolality was demonstrated in all patients. In the first patient, treatment with indomethacin (3 mg/kg per day) resulted in a drop of the insulin and paraminohippurate clearances. In the other three patients urinary excretion of PGE2 was raised, and fell during treatment with hydrochlorothiazide (2 mg/kg per day) and indomethacin (2 mg/kg per day). Urine flow, free water clearance and osmolar clearance decreased during treatment. A combination of both drugs is more effective than hydrochlorothiazide alone and the effect appears to be additive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3153321     DOI: 10.1007/bf00849258

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

Review 1.  Prostaglandins and other arachidonic acid metabolites in the kidney.

Authors:  D Schlondorff; R Ardaillou
Journal:  Kidney Int       Date:  1986-01       Impact factor: 10.612

2.  Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.

Authors:  S Libber; H Harrison; D Spector
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

3.  Determinants of plasma arginine-vasopressin in children.

Authors:  W Rascher; W Rauh; W E Brandeis; K H Huber; K Schärer
Journal:  Acta Paediatr Scand       Date:  1986-01

Review 4.  Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.

Authors:  P Niaudet; M Dechaux; C Trivin; C Loirat; M Broyer
Journal:  Adv Nephrol Necker Hosp       Date:  1984

Review 5.  The regulation of vasopressin function in health and disease.

Authors:  G L Robertson
Journal:  Recent Prog Horm Res       Date:  1976

6.  Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.

Authors:  H W Seyberth; G Knapp; D Wolf; H E Ulmer
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

7.  The role of sodium depletion in hydrochlorothiazide-induced antidiuresis in Brattleboro rats with diabetes insipidus.

Authors:  D G Shirley; S J Walter; J F Laycock
Journal:  Clin Sci Mol Med       Date:  1978-03

8.  The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus.

Authors:  Y Blachar; Z Zadik; M Shemesh; B S Kaplan; S Levin
Journal:  Int J Pediatr Nephrol       Date:  1980-03

9.  Indomethacin impairs water diuresis in the DI rat: role of prostaglandins independent of ADH.

Authors:  J S Stoff; R M Rosa; P Silva; F H Epstein
Journal:  Am J Physiol       Date:  1981-09

10.  The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: water and electrolyte balance.

Authors:  S J Walter; J Skinner; J F Laycock; D G Shirley
Journal:  Clin Sci (Lond)       Date:  1982-12       Impact factor: 6.124

View more
  10 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.

Authors:  Alper Soylu; Belde Kasap; Nilüfer Oğün; Yeşim Oztürk; Mehmet Türkmen; Lies Hoefsloot; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

3.  Long-term growth of children with nephrogenic diabetes insipidus.

Authors:  Horacio Lejarraga; Maria Gracia Caletti; Silvia Caino; Alejandra Jiménez
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

4.  Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.

Authors:  T M Uyeki; F L Barry; S M Rosenthal; R S Mathias
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Nephrogenic diabetes insipidus: treat with caution.

Authors:  Thierry Boussemart; Jacqueline Nsota; Dominique Martin-Coignard; Gérard Champion
Journal:  Pediatr Nephrol       Date:  2009-04-17       Impact factor: 3.714

Review 6.  Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.

Authors:  N Knoers; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

7.  Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders.

Authors:  H W Seyberth; S J Königer; W Rascher; P G Kühl; H Schweer
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 8.  Prostanoids in paediatric kidney diseases.

Authors:  H W Seyberth; A Leonhardt; B Tönshoff; N Gordjani
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

9.  Primary molecular disorders and secondary biological adaptations in bartter syndrome.

Authors:  Georges Deschênes; Marc Fila
Journal:  Int J Nephrol       Date:  2011-09-20

10.  Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study.

Authors:  Cynthia D'Alessandri-Silva; Melinda Carpenter; Rose Ayoob; John Barcia; Aftab Chishti; Alex Constantinescu; Katherine M Dell; Julie Goodwin; Shireen Hashmat; Sandra Iragorri; Cristin Kaspar; Sherene Mason; Jason M Misurac; Melissa Muff-Luett; Christine Sethna; Shweta Shah; Patricia Weng; Larry A Greenbaum; John D Mahan
Journal:  Front Pediatr       Date:  2020-01-21       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.